...
首页> 外文期刊>Arquivos Brasileiros de Oftalmologia >Eficácia do AINE pré-operatório e da técnica de re-dilata??o em minimizar a miose na cirurgia de catarata com laser de femtosegundo
【24h】

Eficácia do AINE pré-operatório e da técnica de re-dilata??o em minimizar a miose na cirurgia de catarata com laser de femtosegundo

机译:飞秒激光白内障手术前术前非甾体抗炎药和再扩张技术对减少瞳孔缩小的功效

获取原文
           

摘要

Purpose: To assess the efficacy of using a nonste-roidal anti-inflammatory drug preoperatively and of applying the re-dilation technique when necessary to minimize pupil size variation when comparing the degree of mydriasis before femtosecond laser pretreatment with that at the beginning of phacoemulsification. Methods: This retrospective study included patients who underwent cataract surgery using the LenSx (Alcon Laboratories, Inc., Fort Worth, TX). Our routine dilating regimen with flurbiprofen, tropicamide, and phenylephrine was used. The re-dilation technique was applied on eyes that manifested with a pupillary diameter that was smaller than the programmed capsulotomy diameter after laser pretreatment. The technique consists of overcoming pupillary contraction by instilling tropicamide and phenylephrine before phacoemulsification. Pupil size was assessed before femtosecond laser application and at the beginning of phacoemulsification. Results: Seventy-five eyes (70 patients) were included. Nine (12%) eyes underwent the re-dilation technique. There was no significant difference in mean pupillary diameter and mean pupillary area between the two studied surgical time points (p=0.412 and 0.437, respectively). The overall pupillary area constriction was 2.4 mm 2 . Immediately before opening the wounds for phacoemulsification, none of the eyes presented with a pupillary diameter 5 mm, and 61 (85.3%) eyes had a pupillary diameter 6 mm. Conclusion: Preoperative administration of nonsteroidal anti-inflammatory drug and the re-dilation technique resulted in no significant pupil size variation in eyes that were pretreated with the femtosecond laser, when comparing the measurements made before the laser application and at the beginning of phacoemulsification. This approach can avoid the need to proceed with cataract extraction with a constricted pupil.
机译:目的:在比较飞秒激光预处理之前的瞳孔散大程度与超声乳化开始时的瞳孔散大程度时,评估术前使用非甾体类抗炎药并在必要时应用再扩张技术以最小化瞳孔大小变化的疗效。方法:这项回顾性研究包括使用LenSx(德克萨斯州沃思堡市爱尔康实验室公司)进行白内障手术的患者。我们采用氟比洛芬,托吡卡胺和去氧肾上腺素的常规扩张方案。重新扩张技术应用于瞳孔直径小于激光预处理后编程的切开切开术直径的眼睛。该技术包括在超声乳化前通过滴注托尼酰胺和去氧肾上腺素来克服瞳孔收缩。飞秒激光应用之前和超声乳化开始时评估瞳孔大小。结果:包括75眼(70例患者)。九只(12%)眼睛接受了重新散瞳技术。在两个研究的手术时间点之间,平均瞳孔直径和平均瞳孔面积没有显着差异(分别为p = 0.412和0.437)。整个瞳孔面积收缩为2.4mm 2。在打开伤口进行超声乳化术之前,瞳孔直径<5 mm的两只眼睛中没有一只,瞳孔直径> 6 mm的一只眼睛为61只(占85.3%)。结论:比较使用激光之前和超声乳化开始时的测量结果,术前使用非甾体类抗炎药和重新散瞳技术不会使使用飞秒激光预处理的眼睛的瞳孔大小变化无明显变化。这种方法可以避免在瞳孔狭窄的情况下进行白内障摘除的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号